Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Neoplasms × copanlisib × Clear all

Status

Completed 3 Terminated 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

tucatinib 1 taletrectinib 1 nirogacestat 1 denileukin diftitox 1 copanlisib 1 atezolizumab 1 Crizotinib 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06238583 2024-02-02

Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors

Bayer

No longer available

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡